No Data
Express News | Resmed Shares Down 4% and Inspire Medical Systems Shares Fall 2.7% in Early Trading
Express News | Shares of Sleep Apnea Device Makers Resmed and Inspire Medical Systems Fall After US FDA Approves Eli Lilly's Weight-Loss Drug to Treat Sleep Apnea
Coupa Announces Inspire May 12-15 and Inspire World Tour Roadshow
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $198
Inspire Medical Systems: Balancing Growth Prospects and Market Challenges – A Hold Rating by Larry Biegelsen
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?